An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.

Informazioni relative al progetto

VasQ

ID dell’accordo di sovvenzione: 710564

DOI

10.3030/710564

Progetto chiuso

Data della firma CE 25 Novembre 2015

Data di avvio 1 Dicembre 2015

Data di completamento 31 Marzo 2016

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

LAMINATE MEDICAL TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - VasQ (An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.)

Periodo di rendicontazione: 2015-12-01 al 2016-03-31

Sintesi del contesto e degli obiettivi generali del progetto

During the Phase 1 feasibility study Laminate undertook a deep study of the technical aspects of its VasQ device including industrialisation and benefits. Business elements examined included deep market analysis and an in-depth customer/end-user study. The activities contributed to the development of a plan to bring the medical device to market and the decision to apply for Phase 2 funding through the SME Instrument.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

Partners were investigated and engaged for carrying out production of the device. The type of clinical trial required to commercialise the device was identified and elaborated. Users were contacted and accounted for in the report. A clinical synopsis for the trial was prepared. The value chain was filled out by the addition of the partners to the consortium.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The only medical device in its field which improves the maturation/usability rate of arteriovenous fistulas over time.

The device.